← Eichor
Condition: Liver Fibrosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Liver Fibrosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
NA · 11 location(s) · Pharmicell Co., Ltd. · NCT05093881Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients
Phase N/A · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07612163Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
NA · 2 location(s) · University of Pennsylvania · NCT06136221Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Fenofibrate in Primary Biliary Cholangitis: a Real World Study
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06755151EGCG for Hepatocellular Carcinoma Chemoprevention
Phase 2 · 1 location(s) · University of Texas Southwestern Medical Center · NCT06015022Liver Damage and Cardiometabolic Disorders in NAFLD
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04036357A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · 186 location(s) · Ipsen · NCT06016842Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Phase N/A · 2 location(s) · University Medical Center Groningen · NCT07585890Microplastics, Cirrhosis and Portal Hypertension
Phase N/A · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07280390Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT06825559Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis
NA · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07286643Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
NA · 2 location(s) · Shanxi Provincial People's Hospital · NCT07116096Copper Supplementation in Cirrhosis
NA · 1 location(s) · University of Washington · NCT07471542Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162Biochemical Response and Clinical Outcomes in Patients With PBC
Phase N/A · 1 location(s) · RenJi Hospital · NCT07449793EUS-guided Response Assessment to NSBB
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06513195VACcination of LIver Transplantation Candidates
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT04446832Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · 205 location(s) · Gilead Sciences · NCT06051617CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Phase 4 · 1 location(s) · Mansoura University · NCT07132515Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients
NA · 3 location(s) · Zhejiang University · NCT07252102Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT05526144Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis
Phase 3 · 11 location(s) · Pharmicell Co., Ltd. · NCT04689152Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NA · 2 location(s) · Pichamol Jirapinyo, MD, MPH · NCT06138821Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients
Phase 4 · 1 location(s) · Tanta University · NCT06881628Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT05045482
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.